BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
Bio-Techne (NASDAQ: TECH) has announced a new distribution partnership with Leader Life Sciences to expand its presence in the Gulf Cooperation Council (GCC) countries.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) has announced a new distribution partnership with Leader Life Sciences to expand its presence in the Gulf Cooperation Council (GCC) countries. The agreement covers distribution in Bahrain, Oman, Qatar, Saudi Arabia, and United Arab Emirates. Leader Life Sciences will distribute Bio-Techne's comprehensive portfolio, including antibodies, proteins, immunoassay kits, enzymes, and spatial biology tools to biopharma companies, laboratories, hospitals, and universities in the GCC region. Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and employs over 3,100 people worldwide.
Positive
- Expansion into new markets through distribution agreement in GCC countries
- Access to established distribution network in Middle East and North Africa region
- $1.2 billion in net sales reported for fiscal 2024
Negative
- None.
Details
News Market Reaction – TECH
The recorded move for TECH in the trading session of this news was +3.54%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Founded in 2020, Leader Life Sciences is a scientific solutions provider dedicated to empowering the research and diagnostic community in the
"We are excited to partner with Leader Life Sciences to expand the reach of our products and services throughout the GCC countries," said Dr. Peter Schüßler, Vice President and General Manager of Bio-Techne's EMEA region. "Leader Life Sciences' extensive distribution network and industry expertise paired with Bio-Techne's innovative portfolio is the ideal combination to catalyze advances in science and medicine in the region."
"We are thrilled to partner with Bio-Techne, a global leader in innovative life sciences solutions. This collaboration marks a pivotal step in our mission to empower researchers, scientists, and diagnosticians in the MENA region. Together, we are committed to providing cutting-edge technologies that accelerate discovery and enhance advancements in diagnostics, reinforcing our dedication to driving progress of the scientific community of the region," said Nirmal Kumar, Managing Director at Leader Life Sciences.
For more information about Bio-Techne and its range of products and services, visit our Website.
About Bio-Techne:
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Bio-Techne Contact:
David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
Leader Life Sciences Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-announces-new-distribution-agreement-with-leader-life-sciences-302311108.html
SOURCE Bio-Techne Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.